Becton, Dickinson and Company
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$27Mgeneral payments (2019-2025)
$1.2Mresearch payments (2019-2025)
26,586clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
- Hemosphere $526K associated (2023-2025)
- Horizon $374K associated (2023-2025)
- Phasix Mesh $322K associated (2023-2025)
- Bd Intelliport $255K associated (2023-2025)
- V. Mueller $64K associated (2023-2025)
- Arista Ah Flexitip $54K associated (2023-2025)
- Bd Onclarity $49K associated (2023-2025)
- Rotarexs 6 F X 135 Cm $32K associated (2023-2025)
- Progel Applicator Spray Tips $30K associated (2023-2025)
- Bard Urinary Drainage Bag $28K associated (2023-2025)
- Arista $28K associated (2023-2025)
- Powerpicc $27K associated (2023-2025)
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Pitamber Devgon | Philadelphia, PA | Internal Medicine | $7,503,852.58 |
| Lawrence Lynn | Columbus, OH | $4,773,178.00 | |
| Alfred Sommer | Baltimore, MD | Ophthalmology | $2,929,267.80 |
| Jack Jeng | South San Francisco, CA | Anesthesiology | $1,285,893.59 |
| John Pesando | Seattle, WA | Hematology & Oncology | $608,328.28 |
| Patrick Hymel | Metairie, LA | $576,095.07 | |
| Stephen Brossette | Birmingham, AL | Clinical Pathology | $441,449.51 |
| Joanne Waldstreicher | New Brunswick, NJ | Endocrinology, Diabetes & Metabolism | $441,045.46 |
| Carrie Byington | Salt Lake City, UT | Pediatric Infectious Diseases | $431,261.30 |
| Michael Ingber | Denville, NJ | Urology | $431,026.99 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.